Clinical Trial Update: Study for the Treatment of Significant Steatosis With Xenical Followed by Treatment of Hepatitis C With Pegasys/Copegus [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating initial treatment of significant fatty liver with Xenical (orlistat) followed by Hepatitis C therapy with Pegasys/Copegus has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Nonalcoholic Fatty Liver Disease

Drugs mentioned

• Copegus (ribavirin)
• Pegasys (pegylated interferon alfa-2a)
• XENICAL (orlistat)

Snippet

Sponsor: Brooke Army Medical Center | Conditions: Fatty Liver, Hepatitis C | Phase 4 | Status: COMPLETED